Atossa Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 02/07/2025 | 9.76 M | $9.21 M | 0.95% | 7.76% |
VANGUARD GROUP INC | 02/11/2025 | 6.62 M | $6.25 M | 0.31% | 5.26% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.81 M | $2.66 M | -0.01% | 2.24% |
STATE STREET CORP | 02/14/2025 | 1.76 M | $1.66 M | 1.34% | 1.40% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.56 M | $1.47 M | 18.90% | 1.24% |
UBS GROUP AG | 02/14/2025 | 1.12 M | $1.06 M | 1,488.72% | 0.89% |
NORTHERN TRUST CORP | 02/14/2025 | 1.03 M | $968,387 | 7.50% | 0.82% |
MORGAN STANLEY | 02/14/2025 | 452,196 | $426,918 | -1.16% | 0.36% |
CITADEL ADVISORS LLC | 02/14/2025 | 427,820 | $403,905 | 164.25% | 0.34% |
JPMORGAN CHASE & CO | 02/12/2025 | 361,296 | $341,100 | 141.44% | 0.29% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 344,858 | $325,580 | 38.43% | 0.27% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 301,648 | $284,786 | -13.22% | 0.24% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 289,727 | $273,531 | -4.58% | 0.23% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 226,176 | $213,533 | 215.13% | 0.18% |
VIRTU FINANCIAL LLC | 02/11/2025 | 208,196 | $197,000 | 311.07% | 0.17% |
BARCLAYS PLC | 02/13/2025 | 191,954 | $181,000 | 14.45% | 0.15% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 189,579 | $178,982 | -3.07% | 0.15% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 189,319 | $178,736 | -5.22% | 0.15% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 170,733 | $161,189 | 0.00% | 0.14% |
JANE STREET GROUP, LLC | 02/14/2025 | 126,704 | $119,621 | -7.47% | 0.10% |
RHUMBLINE ADVISERS | 01/30/2025 | 122,218 | $115,365 | -0.67% | 0.10% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 111,475 | $105,232 | 51.32% | 0.09% |
CITIGROUP INC | 02/12/2025 | 100,024 | $94,433 | 8.75% | 0.08% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 89,837 | $84,815 | -6.64% | 0.07% |
XTX TOPCO LTD | 02/13/2025 | 79,176 | $74,750 | 59.58% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 72,700 | $68,338 | 2.25% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 72,518 | $68,464 | 4.49% | 0.06% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 71,720 | $67,710 | 30.72% | 0.06% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 62,884 | $59,369 | -7.02% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 62,844 | $59,331 | 224.02% | 0.05% |
INVESCO LTD. | 02/13/2025 | 60,344 | $56,970 | 7.70% | 0.05% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 51,198 | $49,000 | 25.58% | 0.04% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 46,331 | $43,741 | -5.66% | 0.04% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 46,001 | $43,000 | 27.70% | 0.04% |
VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 44,232 | $41,759 | -4.57% | 0.04% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 42,400 | $40,030 | 214.07% | 0.03% |
PROSHARE ADVISORS LLC | 02/14/2025 | 35,622 | $33,631 | 49.03% | 0.03% |
CETERA INVESTMENT ADVISERS | 02/14/2025 | 34,227 | $32,314 | -25.82% | 0.03% |
HRT FINANCIAL LP | 02/14/2025 | 31,501 | $29,000 | 100.00% | 0.03% |
REGIONS FINANCIAL CORP | 02/14/2025 | 30,000 | $28,323 | 0.00% | 0.02% |
LPL FINANCIAL LLC | 02/11/2025 | 29,451 | $27,805 | -35.14% | 0.02% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 29,149 | $27,520 | 100.00% | 0.02% |
02/07/2025 | 26,075 | $24,617 | 100.00% | 0.02% | |
02/11/2025 | 25,430 | $24,008 | 100.00% | 0.02% | |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 22,325 | $21,077 | -7.73% | 0.02% |
LVM CAPITAL MANAGEMENT LTD/MI | 01/10/2025 | 21,000 | $20,000 | 0.00% | 0.02% |
CITADEL ADVISORS LLC | 02/14/2025 | 20,900 | $19,732 | -69.08% | 0.02% |
WOLVERINE TRADING, LLC | 02/14/2025 | 18,900 | $18,410 | -49.60% | 0.02% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 18,815 | $17,763 | 100.00% | 0.02% |
CITADEL ADVISORS LLC | 02/14/2025 | 18,200 | $17,183 | 111.63% | 0.01% |
Atossa Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Atossa Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 9.76 M
VANGUARD GROUP INC: 6.62 M
GEODE CAPITAL MANAGEMENT, LLC: 2.81 M
STATE STREET CORP: 1.76 M
RENAISSANCE TECHNOLOGIES LLC: 1.56 M
UBS Group AG: 1.12 M
23.80% of Atossa Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 38.93 M shares in the last 24 months. This purchase volume represents approximately $25.15 M in transactions.